SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Christina Lake Cannabis Corp. CLCFF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Christina Lake Cannabis Corp. (CLCFF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.02. It has a SharesGrow Score of 54/100, indicating a mixed investment profile with 2 out of 7 criteria passed.

Financials: revenue is $15M, +14.4%/yr average growth. Net income is $1M, growing at +14.7%/yr. Net profit margin is 7.3% (thin). Gross margin is 12.9% (-16.7 pp trend).

Balance sheet: total debt is $9M against $17M equity (Debt-to-Equity (D/E) ratio 0.52, moderate). Current ratio is 2.76 (strong liquidity). Debt-to-assets is 31.2%. Total assets: $28M.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 80/100 (Pass), Past 50/100 (Partial), Health 50/100 (Partial), Moat 7/100 (Fail), Future ?/100 (Fail), Income 45/100 (Partial).

CLCFF SharesGrow Score Overview

55/100

SharesGrow Score

Above average fundamentals

View full scorecard →

VALUE 100/100

Valuation — P/E, PEG, Forward PEG

GROWTH 80/100

Financials — average growth

PAST 50/100

strong — trend

HEALTH 50/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 7/100

Gross margin is + market cap

FUTURE 0/100

Analyst outlook — as buy

INCOME 45/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — CLCFF

CLCFF trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

CLCFF: +14.4%/yr revenue is, +14.7%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

CLCFF: 2 / 4 years profitable. weak. Score = 2 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet CLCFF: Debt-to-Equity (D/E) ratio 0.52 (moderate), Current ratio is 2.76 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

CLCFF: Gross margin is 12.9% (-16.7 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 7/100. ≥ 70 = Pass.

View details →

No analyst coverage available for this stock.

CLCFF: Net profit margin is 7.3%. thin (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range0.017-0.052

Volume1.9K

Avg Volume (30D)87.44K

Market Cap$5.95M

Beta (1Y)-0.91

Share Statistics

EPS (TTM)0.00

Shares Outstanding$229.22M

IPO Date2021-01-08

CEOMark Aiken

Financial Highlights & Ratios

Revenue (TTM)$15.07M

Gross Profit$1.94M

EBITDA$2.92M

Net Income$1.1M

Operating Income$2.24M

Total Cash$1.67M

Total Debt$8.73M

Net Debt$7.12M

Total Assets$27.99M

Price / Earnings (P/E)10

Price / Sales (P/S)0.4

Analyst Forecast

Company Info

CountryCA

ExchangeOther OTC

CurrencyUSD

ISINCA17104U1021

Price Chart

CLCFF

Christina Lake Cannabis Corp. ↗ · Other OTC

Healthcare • Drug Manufacturers - Specialty & Generic

0.02 52WK RANGE 0.05

People Also View

Cipher Pharmaceuticals Inc.

HLS Therapeutics Inc.

Crescita Therapeutics Inc.

Alterola Biotech, Inc.

Bionoid Pharma Inc.

CTT Pharmaceutical Holdings, Inc.

CENTR Brands Corp.

Canntab Therapeutics Limited

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message